Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • 介入心脏病学
Long-Term Efficacy and Safety of Transcatheter Patent Foramen Ovale Closure: A 20-Year Follow-Up Study
Posted inCardiology Neurology news

Long-Term Efficacy and Safety of Transcatheter Patent Foramen Ovale Closure: A 20-Year Follow-Up Study

Posted by MedXY By MedXY 03/09/2026
A 20-year follow-up study of 130 patients demonstrates that transcatheter PFO closure is highly effective in preventing recurrent strokes, though long-term antithrombotic therapy increases bleeding risks, particularly in women.
Read More
Long-Term Superiority of Intravascular Imaging: 5-Year Results from the RENOVATE-COMPLEX-PCI Trial
Posted inCardiology news Radiology

Long-Term Superiority of Intravascular Imaging: 5-Year Results from the RENOVATE-COMPLEX-PCI Trial

Posted by MedXY By MedXY 03/09/2026
A 5-year follow-up of the RENOVATE-COMPLEX-PCI trial demonstrates that intravascular imaging-guided PCI significantly reduces major adverse cardiac events by 32% compared to angiography alone in complex lesions, highlighting the long-term clinical benefits of procedural optimization.
Read More
Persistent Risk of Cardiac Structural Complications in TAVR: A Decade-Long Analysis Reveals High Mortality and Stagnant Incidence
Posted inCardiology news

Persistent Risk of Cardiac Structural Complications in TAVR: A Decade-Long Analysis Reveals High Mortality and Stagnant Incidence

Posted by MedXY By MedXY 03/02/2026
A 10-year multicenter study highlights that cardiac structural complications (CSCs) affect 2.1% of TAVR recipients. With a 35% 30-day mortality rate and no decline in incidence over a decade, these events remain a formidable challenge for interventional cardiology teams despite advancing technology.
Read More
Isolated Coronary Artery Ectasia: A High-Risk Phenotype Associated with Doubled Recurrent Infarction Rates
Posted inCardiology news

Isolated Coronary Artery Ectasia: A High-Risk Phenotype Associated with Doubled Recurrent Infarction Rates

Posted by MedXY By MedXY 03/02/2026
A retrospective study reveals that patients with myocardial infarction caused by isolated coronary artery ectasia face significantly higher risks of recurrence and stent thrombosis compared to those without ectasia, highlighting a critical need for tailored antithrombotic strategies in this unique patient population.
Read More
Bridging the Gap: Understanding In-Procedure Variability and Quality Control in the FAVOR III Europe QFR Analysis
Posted inCardiology news

Bridging the Gap: Understanding In-Procedure Variability and Quality Control in the FAVOR III Europe QFR Analysis

Posted by MedXY By MedXY 02/03/2026
The REPEAT-QFR study reveals a modest 72% diagnostic agreement between bedside and core-lab QFR. The findings underscore that angiographic quality and strict adherence to standard operating procedures are essential for accurate, non-invasive coronary physiology assessment in clinical practice.
Read More
The Achilles’ Heel of Left Main Bifurcation: Circumflex Ostium Remains the Primary Site of Restenosis Regardless of Stenting Strategy
Posted inCardiology news

The Achilles’ Heel of Left Main Bifurcation: Circumflex Ostium Remains the Primary Site of Restenosis Regardless of Stenting Strategy

Posted by MedXY By MedXY 01/18/2026
A subanalysis of the EBC MAIN trial reveals that the circumflex ostium is the most frequent site of restenosis following left main bifurcation stenting, occurring in 71% of patients requiring revascularization, regardless of whether a single- or dual-stent technique was employed.
Read More
Vanishing Act: Novel Biodegradable PFO Closure Device Matches Nitinol Efficacy in Landmark Randomized Trial
Posted inCardiology Neurology news

Vanishing Act: Novel Biodegradable PFO Closure Device Matches Nitinol Efficacy in Landmark Randomized Trial

Posted by MedXY By MedXY 01/17/2026
A multicenter randomized trial confirms that a novel biodegradable PFO closure device is noninferior to nitinol devices, achieving high closure rates and disappearing from echocardiography within two years, potentially reducing long-term foreign body risks in cryptogenic stroke patients.
Read More
  • DASH and Other Healthy Diets Linked to Lower Cognitive Decline Risk in Large U.S. Cohorts
  • Restrictive Thyroid Incidentaloma Guidelines Cut Workload Dramatically but Miss a Small Number of Low-Risk Cancers
  • Genetic Variant Modulates Dietary Impact on Glucose Control: Inuit Study Reveals Key Insights
  • Validation of the 2025 ATA Risk Stratification System in a Cohort of Patients with Papillary Thyroid Carcinoma
  • 2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in